EP0909163A4 - Verfahren und mittel zur behandlung der harninkontinenz unter hauptsaechlicher verwendung des (s,r)-glycopyrrolat enantiomers - Google Patents

Verfahren und mittel zur behandlung der harninkontinenz unter hauptsaechlicher verwendung des (s,r)-glycopyrrolat enantiomers

Info

Publication number
EP0909163A4
EP0909163A4 EP97931548A EP97931548A EP0909163A4 EP 0909163 A4 EP0909163 A4 EP 0909163A4 EP 97931548 A EP97931548 A EP 97931548A EP 97931548 A EP97931548 A EP 97931548A EP 0909163 A4 EP0909163 A4 EP 0909163A4
Authority
EP
European Patent Office
Prior art keywords
glycopyrrolate
compositions
methods
urinary incontinence
enantiomerically enriched
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP97931548A
Other languages
English (en)
French (fr)
Other versions
EP0909163A1 (de
Inventor
Vincent L Fabiano
John R Mccullough
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sunovion Pharmaceuticals Inc
Original Assignee
Sepracor Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sepracor Inc filed Critical Sepracor Inc
Publication of EP0909163A1 publication Critical patent/EP0909163A1/de
Publication of EP0909163A4 publication Critical patent/EP0909163A4/de
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D207/10—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/12—Oxygen or sulfur atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00—Indexing scheme relating to specific properties of organic compounds
    • C07B2200/07—Optical isomers

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
EP97931548A 1996-07-01 1997-06-27 Verfahren und mittel zur behandlung der harninkontinenz unter hauptsaechlicher verwendung des (s,r)-glycopyrrolat enantiomers Withdrawn EP0909163A4 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US2115696P 1996-07-01 1996-07-01
US21156P 1996-07-01
PCT/US1997/011639 WO1998000109A1 (en) 1996-07-01 1997-06-27 Methods and compositions for treating urinary incontinence using enantiomerically enriched (s,r)-glycopyrrolate

Publications (2)

Publication Number Publication Date
EP0909163A1 EP0909163A1 (de) 1999-04-21
EP0909163A4 true EP0909163A4 (de) 1999-06-09

Family

ID=21802667

Family Applications (1)

Application Number Title Priority Date Filing Date
EP97931548A Withdrawn EP0909163A4 (de) 1996-07-01 1997-06-27 Verfahren und mittel zur behandlung der harninkontinenz unter hauptsaechlicher verwendung des (s,r)-glycopyrrolat enantiomers

Country Status (2)

Country Link
EP (1) EP0909163A4 (de)
WO (1) WO1998000109A1 (de)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6613795B2 (en) 1996-11-11 2003-09-02 Christian Noe Enantiomerically pure basic arylcycloalkylhydroxycarboxylic esters, processes for their preparation and their use in medicaments
EA200500173A1 (ru) 2002-07-08 2005-08-25 Рэнбакси Лабораториз Лимитед Производные 3,6-дизамещенного азабицикло[3.1.0]гексана в качестве антагонистов мускариновых рецепторов
AU2002347552A1 (en) 2002-12-23 2004-07-14 Ranbaxy Laboratories Limited 1-substituted-3-pyrrolidine derivatives as muscarinic receptor antagonists
US7517905B2 (en) 2003-04-09 2009-04-14 Ranbaxy Laboratories Limited Substituted azabicyclo hexane derivatives as muscarinic receptor antagonists
WO2008034278A1 (en) 2006-09-20 2008-03-27 Woodwelding Ag Anchoring in a construction material
ES2439704T3 (es) 2007-10-25 2014-01-24 Woodwelding Ag Método y dispositivo para anclar una espiga usando vibraciones mecánicas
JO3510B1 (ar) * 2011-03-04 2020-07-05 Heptares Therapeutics Ltd استخدام جلايكوبيرولات لعلاج عدم انتظام دقات القلب
KR20150119468A (ko) 2013-02-28 2015-10-23 더미라, 인코포레이티드 글리코피롤레이트 염
US9006462B2 (en) 2013-02-28 2015-04-14 Dermira, Inc. Glycopyrrolate salts
US8558008B2 (en) 2013-02-28 2013-10-15 Dermira, Inc. Crystalline glycopyrrolate tosylate

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5075312A (en) * 1988-10-27 1991-12-24 Leitman Esther M Novel anti-micturition composition and method
US5525347A (en) * 1995-01-31 1996-06-11 Medical University Of South Carolina Composition and methods for treating performance anxiety

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
DANIEL W. ARMSTRONG ET AL.: "Separation of drug stereoisomers by formation of beta-cyclodextrin inclusion complexes", SCIENCE, vol. 232, no. 4754 part 1, 1986, pages 1132 - 1135, XP002099198 *
See also references of WO9800109A1 *

Also Published As

Publication number Publication date
EP0909163A1 (de) 1999-04-21
WO1998000109A1 (en) 1998-01-08

Similar Documents

Publication Publication Date Title
PL330752A1 (en) Pharmaceutical agent for treating urinary incontinence
AU2593900A (en) Composition and method for treating glaucoma
HK1031174A1 (en) Compositions and methods for treating diabetes
AU4988997A (en) Compositions and methods for treating bone deficit conditions
ZA966838B (en) Method and composition for treating asthma.
AU3828397A (en) Apparatus with valve for treating incontinence
AU6872498A (en) Method and composition for skin treatment
ZA949509B (en) A method and composition for treating biopsy sounds.
AU9214398A (en) Compositions and methods for treating water
ZA978427B (en) Method of treating urinary incontinence
EP0909172A4 (de) Verfahren und zusammensetzungen zur behandlung von harninkontinenz unter verwendung von enantiomer-angereichertem (r,s)-glycopyrrolat
EP0909163A4 (de) Verfahren und mittel zur behandlung der harninkontinenz unter hauptsaechlicher verwendung des (s,r)-glycopyrrolat enantiomers
EP0920419A4 (de) Verbindungen, zusammensetzungen und methoden zur behandlung von grippe
IL129742A (en) Method for treating diseased plants
AU3401199A (en) Method and composition for treating psoriasis
AU3909897A (en) Apparatus for treating incontinence in females
AU5594398A (en) Methods and compositions for preventing and treating bone loss
EP0759745A4 (de) Verfahren und präparate zur erhöhung der calciumaufnahme
GB9420616D0 (en) Method, compositions and use
EP0909170A4 (de) Verfahren und zusammensetzungen zur behandlung von harninkontinenz unter verwendung von enantiomer-angereichertem (s)-tridihexethyl
AU2705195A (en) Incontinence treatment
AU5791698A (en) Methods and compositions for preventing and treating bone loss
EP0874636A4 (de) Tee, geräte und verfahren zur behandlung von hämorrhoiden
EP0938313A4 (de) Verfahren und zusammenstellungen zur behandlung von urininkontinenz durch enantomerisch angereichertes (s)-clidinum
EP0957916A4 (de) Methoden und zusammenstellungen zur behandlung der harninkontinenz mittels durch enantionmorphismus angereichertem (r)-clidinium

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 19990120

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE CH DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE

RHK1 Main classification (correction)

Ipc: A61K 31/40

A4 Supplementary search report drawn up and despatched

Effective date: 19990423

AK Designated contracting states

Kind code of ref document: A4

Designated state(s): AT BE CH DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE

17Q First examination report despatched

Effective date: 20000308

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20011030